Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Charles Burdet et al.|The Lancet Infectious Diseases|2021Cited by 344
Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying DiseaseRomain Lécuyer, Nahéma Issa, Fabrice Camou et al.|CHEST Journal|2024Cited by 49
Epidemiology and Clinical Impact of Respiratory Coinfections at Diagnosis of <i>Pneumocystis jirovecii</i> PneumoniaRomain Lécuyer, Nahéma Issa, Benoît Tessoulin et al.|The Journal of Infectious Diseases|2021Cited by 36
Infective Native Aortic Aneurysm: a Delphi Consensus Document on Treatment, Follow Up, and Definition of CureThomas R. Wyss, Salome Weiss, M Giardini et al.|European Journal of Vascular and Endovascular Surgery|2023Cited by 33
Respiratory management of critically ill pneumocystis pneumonia patients: a multicenter retrospective studyFlorian Reizine, Noémie Coron, Romain Lécuyer et al.|Annals of Intensive Care|2025Cited by 4